MannKind shares drop 18% after FDA says it will pass on new blood pressure drug
Shares of Westlake Village-based MannKind Corp. dropped 18% on Oct. 18, after the U.S. Food and Drug Administration did not approve a hypertension treatment the company is developing with United Therapeutics. In a complete letter response, the FDA declined to approve a new drug application for Tyvasio DPI, a treatment being developed by MannKind and Read More →
Amgen’s investment in Neumora marks a return to neuroscience research
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen goes full speed ahead on biosimilar drugs
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Sansum Institute kept its diabetes research going in a year like no other
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Good Works: French Hospital gets $100K from credit union; Awards in South SLO County
French Hospital Medical Center in San Luis Obispo has received a $100,000 gift from SESLOC Federal Credit Union, the hospital announced Oct. 11. The donation will support French Hospital’s ongoing $130 million expansion project, which will add a four-story patient care tower to the existing hospital campus. The hospital now has $114 million committed to Read More →
Letter to the Editor: Save a life by becoming an organ donor
Dear Editor, Kudos to California Gov. Gavin Newsom, who signed into law Assembly Bill 1374, a critical step in the effort to increase the number of registered organ donors in California. The new law creates a pathway to improve the language of the DMV donor registration with the goal of ensuring public trust and encouraging Read More →
Amgen invests $100M in startup pursuing brain treatments
An Amgen-funded biotech company launched Oct. 7, announcing a strategic partnership between the two companies that includes $100 million in funding and global rights to develop and sell some of Amgen’s experimental drugs for neurodegenerative diseases. Thousand Oaks-based Amgen, one of the largest biotech companies in the world, committed $100 million in equity investment to Read More →
